The structural heterogeneity of α-synuclein, amyloid β, and tau aggregates could form the molecular basis for the broad spectrum of phenotypes seen in synucleinopathies, Alzheimer’s disease, and other tauopathies. This evidence concerns the gene MAPT and Alzheimer disease.